Corporate Governance

Celldex Therapeutics, Inc. is committed to conducting business in a responsible, honest and ethical manner. Good corporate governance is critical to our success as a company and governs our interaction with customers, suppliers, employees and investors. In accordance, the Celldex Board of Directors has adopted these Corporate Governance Guidelines:

Governance Documents

Title Documents

Code of Business Conduct and Ethics

Corporate Governance Guidelines

Committee Charters

Title Documents

Audit Committee Charter

Compensation Committee Charter

Nominating and Corporate Governance Committee Charter

Shareholders and employees can communicate governance matters, compliance matters, including suspected violations of our Code of Business Conduct and Ethics or internal accounting controls or auditing concerns, confidentially to the Celldex Board of Directors through our secure Corporate Governance Hotline.

Communications will be received and reviewed by the Chairman of the Audit Committee and by corporate counsel.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.


Our Pipeline